Laboratory Medicine ›› 2015, Vol. 30 ›› Issue (8): 847-851.DOI: 10.3969/j.issn.1673-8640.2015.08.018
Previous Articles Next Articles
WANG Wei.
Received:
2014-10-23
Online:
2015-08-30
Published:
2015-08-28
CLC Number:
WANG Wei.. The laboratory characteristics of multiple myeloma[J]. Laboratory Medicine, 2015, 30(8): 847-851.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2015.08.018
[1] | KYLE RA, RAJKUMAR SV.Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma[J]. Leukemia, 2009, 23(1): 3-9. |
[2] | KRISTINSSON SY, LANDGREN O, DICKMAN PW, et al.Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003[J]. J Clin Oncol, 2007, 25(15): 1993-1999. |
[3] | KYLE RA, RAJKUMAR SV.Multiple myeloma[J]. N Engl J Med, 2004, 351(18):1860-1873. |
[4] | JAFFE ES, HARRIS NL, STEIN H, et al.Pathology and genetics of tumours of haematopoietic and lymphoid tissues[J]. Lyon: IARC Press, 2001: 144. |
[5] | 王鸿利. 多发性骨髓瘤实验诊断的进展[J].临床内科杂志,2007,24(9):581-583. |
[6] | 陈世伦. 多发性骨髓瘤的实验室检查[J].中国全科医学,2007,10(20):1669-1672. |
[7] | 姜波,蒋志勇,张海军.多发性骨髓瘤的实验室特点及误诊分析[J].临床输血与检验,2010,12(3):268-269. |
[8] | 周胜玉,蔡晓燕.血红蛋白水平对多发性骨髓瘤预后的影响[J].临床和实验医学杂志,2008,7(4):39-41. |
[9] | 邓书会,徐燕,麦玉洁,等.122例多发性骨髓瘤患者ISS分期分析与DS分期、IFM分期的比较[J].中华血液学杂志,2008,29(4):217-221. |
[10] | JACOBSON JL,HUSSEIN MA,BARLOGIE B,et al.A new staging system for multiple myeloma patients based on the Southwest Oncology Group(SWOG) experience[J].Br J Haematol,2003,122(3):441-450. |
[11] | BLADÉ J, ROSIÑOL L. Renal, hematologic and infectious complications in multiple myeloma[J]. Best Pract Res Clin Haematol, 2005, 18(4): 635-652. |
[12] | HERRERA GA, JOSEPH L, GU X, et al . Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia[J]. Arch Pathol Lab Med, 2004 , 128(8) : 875-879. |
[13] | RESIC H,MATARADZIJA A,KUKAVICA N, et al.Renal function in patients with multiple myeloma[J]. Bantao J,2009,7(1):22-25. |
[14] | 李增军,许洪志,徐健.多发性骨髓瘤的误诊分析[J].山东医药,2003,43(25):59. |
[15] | 李斯丹,徐燕,王亚非,等.多发性骨髓瘤骨病的临床特点分析[J].中华血液学杂志,2010,31(4):2012-2032. |
[16] | 葛祥花. 多发性骨髓瘤患者β2-微球蛋白、C 反应蛋白水平的测定及临床意义[J].临床血液学杂志,2003,17(5):242-243. |
[17] | DURIE BG, STROCK-NOVACK D, SALMON SE, et al.Prognostic value of pretreatment serum beta2 miccroglobulin in myeloma: a Southwest Oncology Group Study[J]. Blood, 1990, 75(4): 823-830. |
[18] | GREIPP PR,SAN MIQUEL J,DURIE BG,et al.International staging system for multiple myeloma[J].J Clin Oncol,2005,23(15):3412-3420. |
[19] | 李勇华,侯健,王东星,等.沙立度胺治疗多发性骨髓瘤疗效影响因素分析[J].中华内科杂志,2006,45(7):587-589. |
[20] | BEETHAM R.Detection of Bence-Jones protein in practice[J]. Ann Clin Biochem, 2000, 37(Pt 5):563-570. |
[21] | VAN RHEE F,BOLEJACK V,HOLLMIG K,et al.High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis[J].Blood,2007,110(3):827-832. |
[22] | MEAD GP, CARR-SMITH HD, DRAYSON MT, et al.Serum free light chains for monitoring multiple myeloma[J].Br J Haematol,2004,126(3):348-354. |
[23] | WALDENSTROM J.Studies on conditions associated with disturbed gamma globulin formation(gammopathies)[J].Harvey Lect,1960,56:211-231. |
[24] | HUSSEIN MA,JUTURI JV,LIEBERMAN I.Multiple myeloma:present and future[J].Curr Opin Oncol,2002,14(1):31-35. |
[25] | HUGHES M,DAVIDSON DF,MCCOLL M.Outcomes of discretionary laboratory requesting of serum protein electrophoresis[J].Ann Clin Biochem,2006,43(Pt 5):372-374. |
[26] | 崔凡. 免疫固定电泳检查在多发性骨髓瘤中的应用[J].临床和实验医学杂志,2008,7(1):33-34. |
[27] | 刘汐盈,孙淑艳,宋媛媛.血清免疫固定电泳、蛋白电泳、免疫球蛋白及轻链定量对多发性骨髓瘤临床诊断价值探讨[J].中国实验诊断学,2010,14(5):680-681. |
[28] | DIERLAMM T,LAACK E,DIERLAMM J,et al.IgM myeloma:a report of four cases[J].Ann Hematol,2002,81(3):136-139. |
[29] | ELAINE SJ,NANCY L H,HARALD S,et al.Pathology and genetics of tumours of haematopoietic and lymphoid tissues[M].周小鸽,陈辉树,主译.北京:人民卫生出版社,2006:152-155. |
[30] | 周萍,唐吉斌,曹春鸾,等.62例多发性骨髓瘤的髓象分析[J].安徽医药,2011,15(2):203-204. |
[31] | 江继发, 程玮. 17 例多发性骨髓瘤临床分析[J].安徽医药,2008, 12(6) : 531-532. |
[32] | ISHIKAWA H,TSUYAMA N,KAWANO MM.Interleukin-6-induced proliferation of human myeloma cell associated with CD45 moloeules[J].Int J Hematol,2003,78(2):95-105. |
[33] | 刘莉. 116例多发性骨髓瘤免疫特征表型分析[J].检验医学与临床,2013,10(10):1249-1250. |
[34] | TRCIC RL, SKELIN IK, SUSTERCIC D, et al.Cytogenetics of multiple myeloma[J].Coll Antropol,2010,34(1):41-44. |
[35] | CHANG H,TRIEU Y,QI X,et al.Impact of cytogenetics in patients with relapsed or refractory multiple myeloma treated with bortezomib: adverse effect of 1q21 gains[J].Leuk Res,2011,35(1):95-98. |
[36] | FONSECA R,BLOOD E,RUE M,et al.Clinical and biologic implications of recurrent genomic aberrations in myeloma[J].Blood,2003,101(11):4569-4575. |
[37] | 中华医学会血液学分会.多发性骨髓瘤骨病诊治指南[J].中华血液学杂志,2011,32(10):721-723. |
[38] | 周莉莉. 骨髓瘤的骨质破坏发生机制研究进展[J].中国实验血液学杂志,2007,15(6):1340-1344. |
[39] | PALUMBO A,ANDERSON K.Multiple myeloma[J].N Engl J Med,2011,364(11):1046-1060. |
[1] | WANG Huiying, TANG Yu, DONG Lili, WANG Jing. Role of Mycoplasma pneumoniae RNA determination in diagnosis and efficacy monitoring of pneumonia in children [J]. Laboratory Medicine, 2023, 38(9): 865-869. |
[2] | SUN Xinlin, YE Xingming, LI Qian, ZHAO Lijun. Bronchoscopy combined with sputum Mycobacterium tuberculosis ribonucleic acid and serum Mycobacterium tuberculosis specific antibody determinations for diagnosis of negative pulmonary tuberculosis [J]. Laboratory Medicine, 2023, 38(9): 870-873. |
[3] | HAN Xue, WEN Liu, WAN Yang. Analysis of amniotic fluid chromosome karyotype and genome copy number variation in critical or high-risk pregnant women by Down's screening [J]. Laboratory Medicine, 2023, 38(6): 548-552. |
[4] | ZHANG Chu, WANG Jianhong, LI Rui, XIAO Yanhua, WANG Heng, ZHANG Pinxiao, XU Ningxin, XIA Banban. Results of non-invasive prenatal testing-plus in 5 696 pregnant women [J]. Laboratory Medicine, 2023, 38(6): 553-558. |
[5] | ZHANG Min, WANG Binyu, CHI Weiqun, LIU Yu. Research progress of exosomal non-coding RNA as biomarkers for disease diagnosis [J]. Laboratory Medicine, 2023, 38(6): 594-598. |
[6] | ZHANG Guoliang, LIU Yiwen, HE Yiqing, XU Jing, YANG Cuixia, GAO Feng, LIU Hua. Roles of serum HYAL1 and HA in the auxiliary diagnosis and therapeutic monitoring of colorectal cancer [J]. Laboratory Medicine, 2023, 38(4): 313-319. |
[7] | YU Tingting, WANG Jian. Progress and challenges in diagnosis and treatment of rare diseases [J]. Laboratory Medicine, 2023, 38(2): 103-105. |
[8] | CAI Xiaoyi, LOU Dan, YANG Xingge, WANG Jian. Genetic analysis on 15 cases of suspected Duchenne muscular dystrophy/Becker muscular dystrophy [J]. Laboratory Medicine, 2023, 38(2): 106-111. |
[9] | WANG Dongjiang, GUO Jian. Advance in laboratory diagnosis of invasive fungal infection [J]. Laboratory Medicine, 2023, 38(2): 179-185. |
[10] | WEN Jing, SHI Rui, XIE Jia, LIU Feng, LI Guang, REN Jingjing, LEI Xiaoru, GUO Xiaobo, SONG Yanping. Clinical application of metagenomic next-generation sequencing for determining pathogens in febrile neutropenic patients [J]. Laboratory Medicine, 2022, 37(9): 855-859. |
[11] | SUN Lei, LONG Ju, FAN Zuqian, WU Suping, LIN Guixian, LING Xiuming. sRapid determination of sex chromosome abnormality using double relative quantitative SD-qPCR [J]. Laboratory Medicine, 2022, 37(6): 557-560. |
[12] | GAO Feng. Research progress of new tumor molecular markers in the age of precision medicine:from accurate diagnosis to precision chemotherapy [J]. Laboratory Medicine, 2022, 37(4): 309-312. |
[13] | ZHAO Xuliang, TIAN Ruixia, SHI Youwen, YU Min, JIAO Liuliu, ZHU Fuxi. Role of the prenatal diagnosis of SRPS-5 neonate caused by compound heterozygous mutation of WDR35 by Trio-WES [J]. Laboratory Medicine, 2022, 37(10): 928-933. |
[14] | ZHAO Ying, Gasongzhuoga, Cibai, LIU Zhijuan, XU Yingchun. Application of Xpert MTB/RIF in tuberculosis diagnosis in high altitude localities [J]. Laboratory Medicine, 2021, 36(9): 947-950. |
[15] | CHEN Liyuan, XU Yong, WANG Hui, XU Xiaoxin, XIE Jiansheng. Role of secondary results from non-invasive prenatal testing using cell-free DNA for fetal Klinefelter syndrome [J]. Laboratory Medicine, 2021, 36(8): 785-789. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||